ELOCTATE IV 750, manufactured by Sanofi, contains Efflaloctocog alpha (genetically recombination), a recombinant human coagulation Factor VIII Fc fusion protein used to manage bleeding in hemophilia A. It is provided as 750 IU 1 bottle with dissolving liquid (YJ code: 6343442D3025).
ELOCTATE IV 750
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →